Novavax Inc
NASDAQ:NVAX

Watchlist Manager
Novavax Inc Logo
Novavax Inc
NASDAQ:NVAX
Watchlist
Price: 6.82 USD -1.73% Market Closed
Market Cap: 1.1B USD

Wall Street
Price Targets

NVAX Price Targets Summary
Novavax Inc

Wall Street analysts forecast NVAX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NVAX is 13.03 USD with a low forecast of 6.06 USD and a high forecast of 26.25 USD.

Lowest
Price Target
6.06 USD
11% Downside
Average
Price Target
13.03 USD
91% Upside
Highest
Price Target
26.25 USD
285% Upside
Novavax Inc Competitors:
Price Targets
PRME
Prime Medicine Inc
89% Upside
2171
CARsgen Therapeutics Holdings Ltd
53% Upside
STOK
Stoke Therapeutics Inc
4% Upside
TRDA
Entrada Therapeutics Inc
59% Upside
BMRN
Biomarin Pharmaceutical Inc
54% Upside
CMPX
Compass Therapeutics Inc.
143% Upside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
9% Upside
IPH
Innate Pharma SA
223% Upside

Revenue
Forecast

Revenue Estimate
Novavax Inc

For the last 13 years the compound annual growth rate for Novavax Inc's revenue is 34%. The projected CAGR for the next 4 years is -17%.

34%
Past Growth
-17%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Novavax Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
12%
Average Beat

Net Income
Forecast

Net Income Estimate
Novavax Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-89%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NVAX's stock price target?
Price Target
13.03 USD

According to Wall Street analysts, the average 1-year price target for NVAX is 13.03 USD with a low forecast of 6.06 USD and a high forecast of 26.25 USD.

What is Novavax Inc's Revenue forecast?
Projected CAGR
-17%

For the last 13 years the compound annual growth rate for Novavax Inc's revenue is 34%. The projected CAGR for the next 4 years is -17%.

Back to Top